Table 1.
List of non-invasive clinical and preclinical imaging techniques for monitoring response to immunotherapy in neuro-oncology studies.
CLINICAL IMAGING TECHNIQUES | |||||
---|---|---|---|---|---|
Category of imaging technique | Imaging modality | Research or Clinical Practice | Disease in neuro-oncology studies | Immunotherapy category used in neuro-oncology studies | References |
Structural | Contrast-enhancing MRI | Clinical practice | GBM, CNS metastases | Vaccine, Cell therapy, Checkpoint blockade, Virus | 14, 49 |
FLAIR MRI | Clinical practice | GBM, CNS metastases | Vaccine, Cell therapy, Checkpoint blockade, Virus | 14, 46, 49 | |
Physiological | DTI MRI | Clinical practice | GBM, CNS metastases | Vaccine, Cell therapy, Checkpoint blockade, Virus | 50 |
Diffusion kurtosis imaging MRI | Research | GBM | DC vaccine | 51 | |
q-space imaging MRI | Research | Glioma (low grade) | n/a | 52 | |
Neurite orientation dispersion and density index MRI | Research | GBM | n/a | 53-55 | |
DSC MRI | Clinical practice | GBM, CNS metastases | Vaccine, Cell therapy, Checkpoint blockade, Virus | 47, 51, 56, 57 | |
DCE MRI | Clinical practice | GBM, CNS metastases | Vaccine, Cell therapy, Checkpoint blockade, Virus | 49 | |
Arterial spin label MRI | Research | GBM | n/a | 49 | |
PET hypoxia | Research | GBM | n/a | 58, 59 | |
Molecular | Amino acid PET | Research | GBM, CNS metastases | Vaccine, Checkpoint blockade | 48, 60 |
Antibody-based PET | Research | GBM, CNS metastases | n/a | 61, 62 | |
Proliferation PET | Research | GBM, CNS metastases | Vaccine, Checkpoint blockade | 63 | |
PET reporter gene | Research | GBM | Vaccine, Cell therapy, Virus | 64-68 | |
MRS | Research | GBM | Cell therapy | 69 | |
Immune cell tracking | PET, MRI, SPECT | Research/Clinical practice | GBM | Vaccine, Cell therapy | 70, 71 |
PRECLINICAL IMAGING TECHNIQUES | |||||
Category of imaging technique | Imaging modality | Imaging target | Disease model | Immunotherapy category used in studies | References |
Molecular | Antibody-based PET | Effector immune cells proteins | Syngeneic murine colon or mammary carcinoma | Checkpoint blockade | 72, 73 |
Peptide-based PET | Immune cell cytolytic activity | Syngeneic murine colon carcinoma | Checkpoint blockade | 74 | |
Reporter gene PET | Transgenic T cells | Murine acute myeloid sarcoma | Cell therapy | 75 | |
Reporter gene MRS | Virus-transfected cells | Orthotopic glioma (rat) | Virus | 76 |